-
CDO1 and CELF4 methylation assay as the dominant predictor of endometrial cancer: A cohort analysis across pre- and post-menopausal cohort
Author: Wang, Xiuzhen; Zheng, Lang; Zhu, Genhai; Wang, Shengtan; Li, Wei; Liu, Jun; Gao, Haocheng; Liu, Xiaohang; Li, Guifei; Li, Lei; Hong, Lan
Journal: GYNECOLOGIC ONCOLOGY. 2026; Vol. 206, Issue , pp. 82-92. DOI: 10.1016/j.ygyno.2026.01.776
-
Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cance
Author: Tang, Wenjie; Wang, Lu; Li, Xiaolin; Yan, Xiaohui; Guo, Qiufen; Wu, Qian; Cui, Chunhui; Liu, Bowen; Zhang, Jianbo; Zhang, Lu; Zhang, Xueliang; Li, Dapeng; Xie, Peng
Journal: GYNECOLOGIC ONCOLOGY. 2026; Vol. 205, Issue , pp. 17-26. DOI: 10.1016/j.ygyno.2025.12.007
-
Association between glucagon-like peptide-1 receptor agonists and ovarian cancer survival: A population-based cohort stud
Author: Wang, Min; Dong, Tong; Lucero, Maria; Pan, Wanchun; Wang, Xin; Zhou, Ling; Meng, Yuanguang
Journal: GYNECOLOGIC ONCOLOGY. 2025; Vol. 199, Issue , pp. 57-63. DOI: 10.1016/j.ygyno.2025.06.012
-
GTN misdiagnosed as ectopic pregnancy: a 17-year retrospective cohort stud
Author: Liu, Yuanyuan; Zhou, Yusen; Zhou, Ziying; Rao, Xuan; Feng, Liang; Lu, Weiguo; Li, Xiao
Journal: GYNECOLOGIC ONCOLOGY. 2025; Vol. 199, Issue , pp. 27-31. DOI: 10.1016/j.ygyno.2025.06.010
-
Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node metastasis which is comparable to stage III
Author: Gu, Junjie; Zheng, Wang; Li, Fei; Luo, Chengyan; Yuan, Lin; Sasaki, Ryohei; Seno, Satoshi; Tang, Xinyu; Zhang, Qu; Sun, Xinchen; Qin, Qin
Journal: GYNECOLOGIC ONCOLOGY. 2025; Vol. 198, Issue , pp. 17-24. DOI: 10.1016/j.ygyno.2025.05.007
-
Evaluation of mutations detected in uterine exfoliated cells as a diagnostic tool for endometrial cance
Author: Yang, Wenqing; Shen, Yufei; Tian, Yan; Xiao, Xiao; Shao, Zhuo; Xia, Xuefeng; Li, Lucia; Yang, Siyu; Wen, Xinxin; Liu, Yingzhen; Qiu, Minghui; Li, Yi; Yi, Xin; Liu, Qian; Bai, Jing; Wu, Lisha; Zhang, Yu
Journal: GYNECOLOGIC ONCOLOGY. 2025; Vol. 198, Issue , pp. 33-41. DOI: 10.1016/j.ygyno.2025.05.009
-
AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cance
Author: Lee, Jung-Yun; Boonyapipatb, Sathana; Yuan, Guangwen; Kim, Hee Seung; Lee, Jeong-Won; Wang, Li; Wang, Tao; Wang, Danbo; Yao, Desheng; Liu, Hu; Chang, Chih-Long; Andabekov, Timur Turdeevich; Zhang, Xiang; Wang, Wei; Kim, Yong Man; Sinielnikov, Ivan Volodymyrovych; Wang, Kai; Gao, Yujuan; Mu, Xiyan; Wu, Lingying
Journal: GYNECOLOGIC ONCOLOGY. 2025; Vol. 198, Issue , pp. 25-32. DOI: 10.1016/j.ygyno.2025.04.579
-
Cognitive outcomes after premenopausal risk-reducing Salpingo-oophorectomy: The role of hormone therap
Author: Zhao, Mei; Xu, Lianwei
Journal: GYNECOLOGIC ONCOLOGY. 2025; Vol. 197, Issue , pp. 179-180. DOI: 10.1016/j.ygyno.2025.03.014
